$TLIF providing solutions to combat addiction! Get TOCCA
$TLIF providing solutions to combat addiction! Get TOCCA today!
http://bit.ly/1SmncFG Get TOCCA today!
The information provided above came to you from Uptick Newswire (herein referred to as “us”, “we” or “the website”) is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. All information that we provide is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Furthermore, investing in such securities involves substantial risk of loss and investors should seek advice from financial professionals before investing.
Uptick Newswire provides social media outreach and Investor Relations services for Micro-Cap companies. These are paid services. We may from time to time hold shares of companies featured as payment for services rendered. It is understood that Investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. It is possible that the investor’s entire investment may be lost or impaired due to the speculative nature of the companies listed.
Uptick Newswire makes no recommendation that the securities of the companies listed should be purchased, sold or held by individuals or entities that learn of the listed companies through Uptick Newswire representatives or upticknewswire.com. Any suggestions made by Uptick Newswire staff regarding companies featured on upticknewswire.com is solely that “a suggestion” nothing more. It is our expectation that investors will do their own due diligence.
We recommend that readers use the information found within as a starting point for conducting their own research on the featured company in order to determine their own personal opinion of the company before investing. Uptick Newswire is not liable for any investment decisions made by our readers. Readers should investigate and fully understand all risks before investing.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
In the rough-and-tumble world of mobile advertising, cutting through the noise with real results is no easy feat. Yet Bidease finds itself riding high on a wave of growth—200% revenue increase over back-to-back years. That's no small potatoes, and now they're topping it off with a savvy hire: Dock Kim, the former revenue honcho at Moloco, is on deck as the new VP of...
Continue Reading
Coastal's Big Misstep: A Costly Setback Hey, when a stock drops like a rock on negative news, it's a sign for those on the sidelines to take note. Coastal Financial Corporation, known by its ticker NASDAQ: CCB, felt the hard slap of market reality when a single-day nosedive shaved off a hefty 43% of its stock value. It's all thanks to a whopper of a securities class...
Continue Reading
Surfactants and Epoxy Fuel Dimethylaminopropylamine Demand Hot off the presses, folks! Dimethylaminopropylamine, or DMAPA if you're into acronyms, is gearing up for a steady climb to a $731.9 million market value by the year 2035. That's quite the leap from the $452.6 million we saw back in 2025. According to Credence Research's latest estimates, this amine is hitching...
Continue Reading
The Shifting Sands of Physician Retirement These days, the notion of retirement for physicians resembles less a definitive stop sign and more an unpaved route riddled with unexpected turns. The trusty map of 'work for X years, then retire' is fading. A new guide, NEXT: Flourishing in the New World of Physician Retirement, by Charles R. Stoner, DBA, and Thomas M. Waits,...
Continue Reading
Investors Eye December 15 Deadline Nothing like a looming deadline to stir up some anxiety among investors, and that's exactly what's going down at D-Wave Quantum Inc. right now. We're talking about the class action lawsuit spearheaded by the firm Robbins Geller Rudman & Dowd LLP. They've sent out a call to arms for investors who suffered significant losses from February...
Continue Reading
Asset Searches: Why They Matter to Lawyers Some days you just have to get into the nitty-gritty of legal legwork, and today feels like one of those days. Asset Search USA has come out swinging with a practical guide that no attorney should ignore, especially if they're dealing with the shadowy world of hidden assets. What are we talking about here? We're talking about...
Continue Reading
Biotech Investment: Between a Rock and a Hard Place The U.S. Department of the Treasury just threw a curveball at the biotechnology sector with its proposal to shore up the Comprehensive Outbound Investment National Security (COINS) Act. This ain't just another set of lines on a folded napkin; the new rules would put a chokehold on American investments flowing into...
Continue Reading
Helmets for Kids Initiative Gets Rolling Now, here's a story that's more about community care than cash flow, but hey, sometimes even a grizzled trader like me can nod in appreciation. Christmas Injury Lawyers are putting their money where their mouth is, with the Helmets for Kids initiative staged at two key events in the Lowcountry area. Yep, that's right—the legal...
Continue Reading
Unexpected Third Quarter Tailwinds for First Citizens There are days in this trading gig when a bank I'll barely sneeze at hits out of the park. First Citizens BancShares (NASDAQ:FCNCA) pulled off such a feat, wringing out a third-quarter 2026 performance that beat their own benchmarks. They threw $600 million back to shareholders in repurchased stocks while repaying an...
Continue Reading
Malteurop’s Ambitious Leap into China Folks, it looks like Malteurop, the malting arm of the French VIVESCIA Group, is digging its French roots deep into Chinese soil with a move that screams strategy. They’ve just scooped up the Chunlei Malting Co. plant in Jiangsu province, which cranks out enough malt to sling two billion liters of beer annually. Yeah, that's quite...
Continue Reading
Top 5 Most Recently Viewed Articles
Understanding Your Rights as a Shareholder Your investment means more than just ownership; it brings with it certain rights, especially when you purchase shares in a company like Revance Therapeutics, Inc. (NASDAQ: RVNC). As an investor, it's crucial to be aware of the implications and protections that exist for you, should issues arise regarding the company's management...
Continue Reading
Revolutionizing Pricing Strategies for Insurers In an era where efficiency is paramount, the introduction of the Earnix Price-It™ Connector for Sapiens IDITSuite presents a groundbreaking solution for property and casualty (P&C) insurers. This innovative pricing and rating solution is meticulously crafted to enhance operational efficiencies for insurers seeking to...
Continue Reading
FRC Welcomes Alan Marc Smith as Executive Board Chairman Federal Resources Corporation (FRC) is stepping up its commitment to pioneering advancements in AI technology and security solutions with its recent appointment of Alan Marc Smith as Executive Chairman of the Board of Directors. Known for his remarkable career in the government contracting sector, Smith is a...
Continue Reading
Analyzing Semtech's Performance in the Market Currently, Semtech Inc. (NASDAQ: SMTC) is experiencing a notable trading price of $76.09, reflecting a modest increase of 1.09% in today's session. This upward trend is part of a larger growth narrative for the company, which has seen its stock value rise by an impressive 7.38% over the past month and an astonishing 48.17%...
Continue Reading
Realkredit Danmark Updates Refinancing Schedule for Loans Realkredit Danmark has officially announced an important change to its loan refinancing policy, scheduled to take effect on 25 November. This change impacts the refinancing terms for both FlexLån® and variable rate FlexLife® loans issued in Danish kroner. Understanding the New Refinancing Term Under the new...
Continue Reading